» Articles » PMID: 39668349

Functional Circuits of LYL1 Controlled by Supraphysiological Androgen in Prostate Cancer Cells to Regulate Cell Senescence

Overview
Publisher Biomed Central
Date 2024 Dec 12
PMID 39668349
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Prostate cancer (PCa) is a public health problem mostly reported in developed countries. The androgen receptor (AR) regulates the development and physiological function of normal prostate as well as the proliferation of cancerous prostate tissue. Treatment with supraphysiological androgen levels (SAL) is used in bipolar androgen therapy and inhibits PCa growth, suggesting SAL induces a tumor suppressive program. It was shown that SAL induces cellular senescence, in PCa cell lines, human tumor samples and in xenografted mouse tumor model.

Methods: Transcriptome and ChIP-seq analysis, PCa spheroids, knockdown (KD), co-immunoprecipitation, qRT-PCR, immune detection, in situ histochemistry.

Results: Here we show that LYL1 is upregulated by the clock gene BHLHE40 in both C4-2 and LNCaP cells and mediates SAL-induced cellular senescence. LYL1 is a transcriptional co-factor with oncogenic activity in leukemia. However, analysis of a large cohort of PCa patients shows that LYL1 expression is reduced during PCa development and reduced expression is significantly associated with reduced overall survival. SAL induces the expression of LYL1 through upregulation of BHLHE40. On the other hand, the KD of LYL1 enhances BHLHE40 expression via a negative feedback loop including p27kip1. Regulatory feedback loops were identified by rescue experiments. Functional analysis revealed that KD of BHLHE40 reduces whereas LYL1 KD enhances p27kip1 levels. The KD of p27kip1 suggests that this cell cycle inhibitor is a mediator of cellular senescence by the BHLHE40 - LYL1 regulatory loop. Interestingly, ChIP-seq data revealed recruitment of both AR and BHLHE40 to the LYL1 gene indicating that LYL1 is a novel direct target of both factors. Furthermore, RNA-seq data from C4-2 cells suggests that LYL1 and BHLHE40 encompass a large overlap of genes by SAL suggesting a co-regulatory activity controlled by androgens. In line with this, co-immunoprecipitation suggests LYL1 is in a complex with BHLHE40 and the AR.

Conclusions: Three novel feed-back loops and a novel AR- BHLHE40 / LYL1 -p27kip1 axis has been identified mediating cellular senescence in PCa cells.

Citing Articles

H2AJ Is a Direct Androgen Receptor Target Gene That Regulates Androgen-Induced Cellular Senescence and Inhibits Mesenchymal Markers in Prostate Cancer Cells.

Heidari Horestani M, Atri Roozbahani G, Baniahmad A Cancers (Basel). 2025; 17(5).

PMID: 40075640 PMC: 11898987. DOI: 10.3390/cancers17050791.

References
1.
Yu G, Wang L, Han Y, He Q . clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012; 16(5):284-7. PMC: 3339379. DOI: 10.1089/omi.2011.0118. View

2.
Maria Flores J, Martin-Caballero J, Garcia-Fernandez R . p21 and p27 a shared senescence history. Cell Cycle. 2014; 13(11):1655-6. PMC: 4111707. DOI: 10.4161/cc.29147. View

3.
Sirma H, Broemel M, Stumm L, Tsourlakis T, Steurer S, Tennstedt P . Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis. Oncol Lett. 2013; 6(5):1245-1252. PMC: 3813765. DOI: 10.3892/ol.2013.1563. View

4.
Heidari Horestani M, Atri Roozbahani G, Baniahmad A . The clock gene BHLHE40 and atypical CCNG2 control androgen-induced cellular senescence as a novel tumor suppressive pathway in prostate cancer. J Exp Clin Cancer Res. 2024; 43(1):174. PMC: 11188219. DOI: 10.1186/s13046-024-03097-6. View

5.
Zhong Y, Jiang L, Hiai H, Toyokuni S, Yamada Y . Overexpression of a transcription factor LYL1 induces T- and B-cell lymphoma in mice. Oncogene. 2007; 26(48):6937-47. DOI: 10.1038/sj.onc.1210494. View